IDXX

Idexx Laboratories Inc

Stock · NASDAQ

Program summary

FieldValueAs ofSource
Current authorization$53.8bnEST30-Sep-2610-Q filed 02-Nov-26
Remaining authorization$1.6bnEST30-Sep-2610-Q filed 02-Nov-26
Program expiryn/a—
Repurchased last quarter$112m31-Aug-2610-Q filed 02-Nov-26
Has used an ASRNo—

Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.

Programs

Authorized onAuthorizedRemainingExpiresTerms
13-Aug-99$53.8bnEST
78.0m sh
$1.6bnEST
2.4m sh left
n/aBoard of Directors has approved the repurchase of up to 78 million shares of common stock in the open market or in negotiated transactions pursuant to the Company's share repurchase program. The initial program was approved and announced on August 13, 1999, and the maximum number of shares that may be purchased under the program has been increased by the Board of Directors on numerous occasions.…10-Q filed 02-Nov-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. ≈$206m
    Apr ’26
  2. May ’26
  3. Jun ’26
  4. Jul ’26
  5. ≈$15m
    Aug ’26
Month endedSharesWithheld & otherAvg price≈ ValueSource
31-Aug-2626,400—$585.84$15m10-Q filed 02-Nov-26
31-Jul-26172,200—$559.54$96m10-Q filed 02-Nov-26
30-Jun-2684,784484$558.85$47m10-Q filed 04-Aug-26
31-May-26140,54545$562.67$79m10-Q filed 04-Aug-26
Filings through 30-Sep-26· checked 18-Nov-26